triamcinolone acetonide has been researched along with n-pentanol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abellán Guillén, A; Cordeiro, MN; Garrido Escudero, A; Morales Helguera, A; Pérez-Garrido, A | 1 |
| Cavet, ME; López, FJ; Salvador-Silva, M; VanderMeid, KR; Ward, KW; Zhang, JZ | 1 |
| Bäumer, W; Rossbach, K; Schmidt, BH | 1 |
3 other study(ies) available for triamcinolone acetonide and n-pentanol
| Article | Year |
|---|---|
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
Topics: beta-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Organic Chemicals; Quantitative Structure-Activity Relationship | 2009 |
BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells.
Topics: Anti-Inflammatory Agents; Astrocytes; Benzofurans; Cell Extracts; Cells, Cultured; Conjunctiva; Dexamethasone; Endothelial Cells; Epithelial Cells; Epithelium, Corneal; Eye; Fibroblasts; Humans; I-kappa B Proteins; Intercellular Adhesion Molecule-1; Interleukin-1beta; Lipopolysaccharides; Mitogen-Activated Protein Kinases; NF-kappa B; Optic Nerve; Pentanols; Phosphorylation; Quinolines; Receptors, Glucocorticoid; Triamcinolone Acetonide | 2009 |
The selective glucocorticoid receptor agonist mapracorat displays a favourable safety-efficacy ratio for the topical treatment of inflammatory skin diseases in dogs.
Topics: Administration, Topical; Animals; Benzofurans; Dermatitis; Dermatologic Agents; Dog Diseases; Dogs; Female; Male; Pentanols; Quinolines; Receptors, Glucocorticoid; Treatment Outcome; Triamcinolone Acetonide; Tumor Necrosis Factor-alpha | 2017 |